Short answer
Crinetics Pharmaceuticals, Inc. (CRNX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Crinetics reported FY2025 financial results (period ended Dec 31, 2025) via press release on Feb 26, 2026.
Crinetics Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Crinetics reported FY2025 financial results (period ended Dec 31, 2025) via press release on Feb 26, 2026
- Full results in Exhibit 99.1: key figures, revenue, and guidance details found there
- Filing is Reg FD-safe (not "filed" under Exchange Act Section 18), limiting litigation liability
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Crinetics Pharmaceuticals, Inc. 8-K filings
Get the next CRNX 8-K as it lands
Follow CRNX for push alerts, or ask the research agent what this filing means.